Correlation Between Stagwell and Centessa Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Stagwell and Centessa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stagwell and Centessa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stagwell and Centessa Pharmaceuticals PLC, you can compare the effects of market volatilities on Stagwell and Centessa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stagwell with a short position of Centessa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stagwell and Centessa Pharmaceuticals.

Diversification Opportunities for Stagwell and Centessa Pharmaceuticals

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Stagwell and Centessa is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Stagwell and Centessa Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Centessa Pharmaceuticals and Stagwell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stagwell are associated (or correlated) with Centessa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Centessa Pharmaceuticals has no effect on the direction of Stagwell i.e., Stagwell and Centessa Pharmaceuticals go up and down completely randomly.

Pair Corralation between Stagwell and Centessa Pharmaceuticals

Given the investment horizon of 90 days Stagwell is expected to generate 0.75 times more return on investment than Centessa Pharmaceuticals. However, Stagwell is 1.34 times less risky than Centessa Pharmaceuticals. It trades about 0.35 of its potential returns per unit of risk. Centessa Pharmaceuticals PLC is currently generating about 0.21 per unit of risk. If you would invest  645.00  in Stagwell on August 31, 2024 and sell it today you would earn a total of  146.00  from holding Stagwell or generate 22.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Stagwell  vs.  Centessa Pharmaceuticals PLC

 Performance 
       Timeline  
Stagwell 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Stagwell are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal technical and fundamental indicators, Stagwell showed solid returns over the last few months and may actually be approaching a breakup point.
Centessa Pharmaceuticals 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Centessa Pharmaceuticals PLC are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Centessa Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

Stagwell and Centessa Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Stagwell and Centessa Pharmaceuticals

The main advantage of trading using opposite Stagwell and Centessa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stagwell position performs unexpectedly, Centessa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Centessa Pharmaceuticals will offset losses from the drop in Centessa Pharmaceuticals' long position.
The idea behind Stagwell and Centessa Pharmaceuticals PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities